BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 34050913)

  • 61. The Expanding Spectrum of Mutations in Hereditary Angioedema.
    Veronez CL; Csuka D; Sheikh FR; Zuraw BL; Farkas H; Bork K
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2229-2234. PubMed ID: 33746090
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
    Valerieva A; Caccia S; Cicardi M
    Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Genetics of Hereditary Angioedema: A Review.
    Santacroce R; D'Andrea G; Maffione AB; Margaglione M; d'Apolito M
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34065094
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic approaches in hereditary angioedema.
    Antoniu SA
    Clin Rev Allergy Immunol; 2011 Aug; 41(1):114-22. PubMed ID: 21279474
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes.
    Joseph K; Bains S; Tholanikunnel BG; Bygum A; Aabom A; Koch C; Farkas H; Varga L; Ghebrehiwet B; Kaplan AP
    Allergy; 2015 Jan; 70(1):115-9. PubMed ID: 25186184
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hereditary angioedema: a brief review of new developments.
    Altman KA; Naimi DR
    Curr Med Res Opin; 2014 May; 30(5):923-30. PubMed ID: 24432781
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathophysiology of hereditary angioedema.
    Zuraw BL; Christiansen SC
    Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Guidelines for the diagnosis and treatment of hereditary angioedema].
    Marković AS; Rozmanić V; Anić B; Aberle N; Racić G; Novak S; Sunara D; Grdinić B; Karadza-Lapić L; Radas MR; Karanović B; Kvenić B
    Lijec Vjesn; 2014; 136(5-6):117-29. PubMed ID: 25154179
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
    Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
    Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mast cell degranulation and bradykinin-induced angioedema - searching for the missing link.
    Porebski G; Dziadowiec A; Rybka H; Kitel R; Kwitniewski M
    Front Immunol; 2024; 15():1399459. PubMed ID: 38812508
    [TBL] [Abstract][Full Text] [Related]  

  • 72. C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema.
    Kaplan AP; Pawaskar D; Chiao J
    J Allergy Clin Immunol Pract; 2020 Mar; 8(3):892-900. PubMed ID: 31655295
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Laboratory Approaches for Assessing Contact System Activation.
    Christiansen SC; Zuraw BL
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):527-539. PubMed ID: 28687107
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
    Castelli R; Zanichelli A; Cugno M
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Panorama of Primary Angioedema in the Brazilian Population.
    Veronez CL; Mendes AR; Leite CS; Gomes CP; Grumach AS; Pesquero JB;
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2293-2304.e5. PubMed ID: 33276216
    [TBL] [Abstract][Full Text] [Related]  

  • 76. C1-esterase inhibitor (Cinryze
    Gupta R; Balduzzi J; Davis-Lorton M
    Immunotherapy; 2018 Jun; 10(8):635-642. PubMed ID: 29569504
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
    Henry Li H; Riedl M; Kashkin J
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study.
    Savarese L; Bova M; De Falco R; Guarino MD; De Luca Picione R; Petraroli A; Senter R; Traverso C; Zabotto M; Zanichelli A; Zito E; Alessio M; Cancian M; Cicardi M; Franzese A; Perricone R; Marone G; Valerio P; Freda MF
    Orphanet J Rare Dis; 2018 Jul; 13(1):115. PubMed ID: 30005674
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Leveraging Genetics for Hereditary Angioedema: A Road Map to Precision Medicine.
    Germenis AE; Rijavec M; Veronez CL
    Clin Rev Allergy Immunol; 2021 Jun; 60(3):416-428. PubMed ID: 33507496
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chapter 22: Hereditary and acquired angioedema.
    Georgy MS; Pongracic JA
    Allergy Asthma Proc; 2012; 33 Suppl 1():73-76. PubMed ID: 22794695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.